Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Literature DB >> 26328266

Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Maria E Lozada¹, Roongruedee Chaiteerakij², Lewis R Roberts¹.

Abstract

Entities: Chemical Disease Gene Species

Keywords: Bile Duct Cancer; Diagnosis; Early detection; Liver Cancer; Surveillance

Year: 2015 PMID： 26328266 PMCID： PMC4551404 DOI： 10.1007/s11901-015-0261-y

Source DB: PubMed Journal: Curr Hepatol Rep ISSN： 2195-9595

× No keyword cloud information.

83 in total

Review 1. Phases of biomarker development for early detection of cancer.

Authors: M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal: J Natl Cancer Inst Date: 2001-07-18 Impact factor: 13.506

2. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.

Authors: Emily G Barr Fritcher; Jesse S Voss; Sarah M Jenkins; Ravi K Lingineni; Amy C Clayton; Lewis R Roberts; Kevin C Halling; Jayant A Talwalkar; Gregory J Gores; Benjamin R Kipp
Journal: Cancer Cytopathol Date: 2013-07-09 Impact factor: 5.284

3. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.

Authors: Jennifer A Flemming; Ju Dong Yang; Eric Vittinghoff; W Ray Kim; Norah A Terrault
Journal: Cancer Date: 2014-07-16 Impact factor: 6.860

4. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors: Li Huang; Wei Chen; Peiwen Liang; Wenjie Hu; Kunsong Zhang; Shunli Shen; Jiancong Chen; Zhaohui Zhang; Bin Chen; Yuyan Han; Fanyin Meng; Sharon DeMorrow; Xiaoyu Yin; Jiaming Lai; Lijian Liang
Journal: Dig Dis Sci Date: 2014-12-09 Impact factor: 3.199

5. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.

Authors: Hashem B El-Serag; Fasiha Kanwal; Jessica A Davila; Jennifer Kramer; Peter Richardson
Journal: Gastroenterology Date: 2014-01-23 Impact factor: 22.682

Review 6. Classification, diagnosis, and management of cholangiocarcinoma.

Authors: Nataliya Razumilava; Gregory J Gores
Journal: Clin Gastroenterol Hepatol Date: 2012-09-13 Impact factor: 11.382

7. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Authors: Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S Lok; Paul D Wagner; Sudhir Srivastava; Myron Schwartz
Journal: Gastroenterology Date: 2009-04-09 Impact factor: 22.682

Review 8. Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success.

Authors: Benjamin R Kipp; Emily G Barr Fritcher; Jennifer E Pettengill; Kevin C Halling; Amy C Clayton
Journal: Cancer Cytopathol Date: 2013-04-30 Impact factor: 5.284

9. Management of hepatocellular carcinoma: an update.

Authors: Jordi Bruix; Morris Sherman
Journal: Hepatology Date: 2011-03 Impact factor: 17.425

10. Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.

Authors: Andre Nogueira da Costa; Amelie Plymoth; Daniela Santos-Silva; Sandra Ortiz-Cuaran; Suzy Camey; Paule Guilloreau; Suleeporn Sangrajrang; Thiravud Khuhaprema; Maimuna Mendy; Olufunmilayo A Lesi; Hee-Kyung Chang; Jin-Kyoung Oh; Duk-Hee Lee; Hai-Rim Shin; Gregory D Kirk; Philippe Merle; Laura Beretta; Pierre Hainaut
Journal: Int J Cancer Date: 2014-05-15 Impact factor: 7.396

3 in total